Stories by Issue
COVID-19
Newly updated Pfizer and Moderna boosters to be distributed next month
Both Pfizer and Moderna bivalent boosters are expected to be distributed in September.
This bivalent booster consists of the old vaccine formula with a new one that fights against omicron variants including BA.4 and BA.5.
Novavax vaccine now recommended for public use
On Tuesday the U.S. Centers for Disease Control and Prevention (CDC) recommended the use of the new vaccine by Novavax for people ages 18 and above.
FDA authorizes new COVID-19 vaccine from Novavax
The Food and Drug Administration authorized a new COVID-19 vaccine developed by Novavax on Wednesday.
Novavax is a biotechnology company in Maryland that received significant federal funding to produce the shot.
What we know about Omicron and the BA.5 variant
Accounting for 65 percent of last week’s COVID-19 cases, the coronavirus subvariant BA.5 — a sister variant of Omicron — has become dominant in the United States.
White house health experts urging people to get boosted now
The newly updated booster vaccine is adapted to not only fight against COVID-19 and Omicron but will also help fight against the new variants.
Wasco’s youth shares their reasons for getting the COVID-19 vaccine
The City of Wasco held a vaccination clinic on June 26, where free vaccines, COVID tests, boxes of food, hand sanitizers, masks, and other resources were provided.